| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Abstracts From: Hematologic Malignancies 2009 Brussels, Belgium September 30 – October 3, 2009
|
|
|
2009
|
9 |
6 |
p. 469-470
2 p.
|
article
|
| 2 |
Behçet's Disease in a Patient With Myelodysplastic Syndrome
|
Kovacs, Erzsebet
|
|
2009
|
9 |
6 |
p. 459-461
3 p.
|
article
|
| 3 |
Bing-Neel Syndrome: A Case Report and Systematic Review of Clinical Manifestations, Diagnosis, and Treatment Options
|
Grewal, Jaspreet S.
|
|
2009
|
9 |
6 |
p. 462-466
5 p.
|
article
|
| 4 |
Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
|
Duarte, Bruno K.L.
|
|
2009
|
9 |
6 |
p. 449-454
6 p.
|
article
|
| 5 |
Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
|
Fava, Carmen
|
|
2009
|
9 |
6 |
p. E41-
1 p.
|
article
|
| 6 |
Complex Immunophenotypic Changes as Prognosis Panel in Chronic Lymphocytic Leukemia
|
Bumbea, Horia
|
|
2009
|
9 |
6 |
p. E37-
1 p.
|
article
|
| 7 |
Concomitant or Sequential Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML): A Molecular and Clinical Survey
|
Said, Carla
|
|
2009
|
9 |
6 |
p. E34-
1 p.
|
article
|
| 8 |
Current Diagnostic Approach in Acute Myeloid Leukemia in the Republic of Macedonia: A Proposal for Minimal Screening-Based Clinical Stratification
|
Hadzi-Pecova, Liljana
|
|
2009
|
9 |
6 |
p. E44-
1 p.
|
article
|
| 9 |
Dasatinib and Chronic Myeloid Leukemia: Two-Year Follow-up in Eight Clinical Trials
|
Pavlů, Jiří
|
|
2009
|
9 |
6 |
p. 417-424
8 p.
|
article
|
| 10 |
Evaluation of the Long-Term Tolerability and Clinical Benefit of Vorinostat in Patients With Advanced Cutaneous T-Cell Lymphoma
|
Duvic, Madeleine
|
|
2009
|
9 |
6 |
p. 412-416
5 p.
|
article
|
| 11 |
Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autologous Peripheral Blood Stem Cell Transplantation After Rituximab-Containing Induction Chemotherapy With In Vivo Purging in Relapsed or Refractory Follicular Lymphoma
|
Kato, Harumi
|
|
2009
|
9 |
6 |
p. 443-448
6 p.
|
article
|
| 12 |
Feasibility and Safety of Maintenance Therapy in the Treatment of Acute Myeloid Leukemia
|
Krug, Utz
|
|
2009
|
9 |
6 |
p. E43-
1 p.
|
article
|
| 13 |
Granulomatous Slack Skin: Assessment of Disease Progression and Treatment Response Using Positron Emission Tomography/Computed Tomography
|
Sheng, Youyu
|
|
2009
|
9 |
6 |
p. 455-458
4 p.
|
article
|
| 14 |
Is Platelet Aggregation a Useful Investigation in Assessing the Risk of Thrombosis in Patients With JAK-Positive Chronic Myeloproliferative Disorders? Brief Report: A Study on 14 Patients
|
Popov, V.M.
|
|
2009
|
9 |
6 |
p. E45-
1 p.
|
article
|
| 15 |
Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation
|
Fava, Carmen
|
|
2009
|
9 |
6 |
p. E42-
1 p.
|
article
|
| 16 |
Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse
|
Krejci, Marta
|
|
2009
|
9 |
6 |
p. 436-442
7 p.
|
article
|
| 17 |
Metronomic Cyclophosphamide and Vinblastine in Refractory Lymphoma
|
Geurs, Filip
|
|
2009
|
9 |
6 |
p. E33-
1 p.
|
article
|
| 18 |
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
|
Wierda, William
|
|
2009
|
9 |
6 |
p. E36-
1 p.
|
article
|
| 19 |
Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab
|
Badoux, Xavier
|
|
2009
|
9 |
6 |
p. E39-E40
nvt p.
|
article
|
| 20 |
Protein Kinase C Beta II Expression in Diffuse Large B-Cell Lymphoma Predicts for Inferior Outcome of Anthracycline-Based Chemotherapy With And Without Rituximab
|
Nandurkar, Harshal
|
|
2009
|
9 |
6 |
p. E31-
1 p.
|
article
|
| 21 |
Selected Clinical Trials in Diffuse Large B-Cell Lymphoma and T-Cell Lymphoma
|
|
|
2009
|
9 |
6 |
p. 467-468
2 p.
|
article
|
| 22 |
Serum Levels of Total-RANKL in Multiple Myeloma
|
Jakob, Christian
|
|
2009
|
9 |
6 |
p. 430-435
6 p.
|
article
|
| 23 |
The Early- and Intermediate-Term Toxicity to Primitive Hematopoietic Progenitor Cells of Three Chemotherapy Regimens for Advanced Hodgkin Lymphoma
|
Gobbi, Paolo G.
|
|
2009
|
9 |
6 |
p. 425-429
5 p.
|
article
|
| 24 |
The Effect of Zoledronic Acid on the Prevention of Bone Loss in Lymphoma Patients Receiving First-line Therapy
|
Westin, Jason
|
|
2009
|
9 |
6 |
p. E30-
1 p.
|
article
|
| 25 |
The Impact of Selected Apoptotic Markers and Adhesion Molecules on the Treatment Outcome of Chronic Lymphocytic Leukemia
|
Abdelhamid, Thoraya
|
|
2009
|
9 |
6 |
p. E35-
1 p.
|
article
|
| 26 |
Valproic Acid, a Histone Deacetylase Inhibitor, Induces Apoptosis, Inhibits Proliferation, and Synergizes With Chemotherapy: The Rationale to Combine it for the Treatment of B-Cell Chronic Lymphocytic Leukemia
|
Stamatopoulos, Basile
|
|
2009
|
9 |
6 |
p. E38-
1 p.
|
article
|
| 27 |
We Should Have a Dream: Unlocking the Workings of the Genome in Cutaneous T-Cell Lymphomas
|
Porcu, Pierluigi
|
|
2009
|
9 |
6 |
p. 409-411
3 p.
|
article
|
| 28 |
Yttrium-90 Microsphere Radioembolization of the Spleen: A New Approach for the Treatment of Malignant Lymphomatous Splenomegaly
|
Nguyen, Jasmine
|
|
2009
|
9 |
6 |
p. E32-
1 p.
|
article
|
Journal description